1. Home
  2. SIBN vs DBVT Comparison

SIBN vs DBVT Comparison

Compare SIBN & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

N/A

Current Price

$19.36

Market Cap

778.8M

Sector

Health Care

ML Signal

N/A

Logo DBV Technologies S.A.

DBVT

DBV Technologies S.A.

N/A

Current Price

$9.81

Market Cap

850.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIBN
DBVT
Founded
2008
2002
Country
United States
France
Employees
N/A
90
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
778.8M
850.9M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
SIBN
DBVT
Price
$19.36
$9.81
Analyst Decision
Strong Buy
Buy
Analyst Count
9
7
Target Price
$25.22
★ $38.78
AVG Volume (30 Days)
★ 539.0K
433.0K
Earning Date
11-09-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.33
10.26
EPS
★ N/A
N/A
Revenue
★ $67,301,000.00
$5,636,000.00
Revenue This Year
$15.53
N/A
Revenue Next Year
$15.64
$1,630.16
P/E Ratio
★ N/A
N/A
Revenue Growth
21.53
★ 35.77
52 Week Low
$11.48
$9.36
52 Week High
$21.89
$26.19

Technical Indicators

Market Signals
Indicator
SIBN
DBVT
Relative Strength Index (RSI) 55.12 28.07
Support Level $17.95 N/A
Resistance Level $19.35 $14.90
Average True Range (ATR) 0.65 0.54
MACD 0.06 -0.15
Stochastic Oscillator 64.39 11.54

Price Performance

Historical Comparison
SIBN
DBVT

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: